1Neumann HP, Hoegerle S, Manz T, et al. How many pathways to pheochromocytoma. Semin Nephrol, 2002,22: 89-99.
2Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD,a mitochondrial complex Ⅱ gene, in hereditary paraganglioma. Science, 2000,287: 848-851.
3Hirawake H, Taniwaki M, Tamura A, et al. Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase. Biochim Biophys Acta, 1999,1412: 295-300.
4Chandel NS, Maltepe E, Mathieu CE, et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Sci USA, 1998,95:11715-11720.
5Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex Ⅱ in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet,2001,69:1186-1197
6Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet, 2001,69:49-54.
7Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet,2000,26:268-270.
8Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet,2002,39:178-183.
9Astuti D, Douglas F, Lennard TW, et al. Germline SDHD mutation in familial phaeochromocytoma. Lancet,2001,357:1181-1182.
10Cascon A, Ruiz-Llorente S, Cebrian A, et al. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur J Hum Genet,2002,10:457-461.
